Designing the Free Drugs List in Nepal
Open Access
- 1 January 2017
- journal article
- research article
- Published by SAGE Publications in MDM Policy & Practice
- Vol. 2 (1)
Abstract
As more countries provide free health care, pharmaceutical reimbursement lists are becoming a concern, especially in low- and middle-income countries. In 2007, Nepal decreed that health is a human right and began basic health coverage for a target group of the poor, destitute, elderly, and disabled. The Ministry of Health and Population (MoHP) also provided 40 drugs without cost to all citizens through the Free Drugs List (FDL) program. The FDL was later expanded from 40 to 70 drugs; however, the process of review and update remains unclear. To propose a mechanism for future development of the FDL, we conducted a document review and in-depth consultations with representatives from the MoHP and the World Health Organization Country Office during a workshop in Kathmandu. The FDL suffers from lack of an appropriate process, gaps between the listed drugs and Nepal’s burden of disease, and no consideration of the unit costs or cost-effectiveness of drugs included in the list. We propose a new drug selection process that is a variant of the health technology assessment process. This process can be applied not only in Nepal but also in other resource-limited countries that wish to ensure their citizens’ access to essential medicines through a pharmaceutical reimbursement list.Keywords
This publication has 10 references indexed in Scilit:
- Is diabetes and hypertension screening worthwhile in resource-limited settings? An economic evaluation based on a pilot of a Package of Essential Non-communicable disease interventions in BhutanHealth Policy and Planning, 2014
- Selection of Essential Medicines for Diabetes in Low and Middle Income Countries: A Survey of 32 National Essential Medicines ListsPLOS ONE, 2014
- The Role of Evidence in the Decision-Making Process of Selecting Essential Medicines in Developing Countries: The Case of TanzaniaPLOS ONE, 2014
- The use of economic evaluation for guiding the pharmaceutical reimbursement list in ThailandZeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen, 2014
- The Availability, Pricing and Affordability of Three Essential Asthma Medicines in 52 Low- and Middle-Income CountriesPharmacoEconomics, 2013
- Improving health system quality in low- and middle-income countries that are expanding health coverage: a framework for insuranceInternational Journal for Quality in Health Care, 2013
- Understanding the burden of disease in Nepal: a call for local evidence.2013
- Efficiency or equity: value judgments in coverage decisions in ThailandJournal of Health Organization and Management, 2012
- National list of essential medicines of IndiaJournal of Postgraduate Medicine, 2012
- 25 years of the WHO essential medicines lists: progress and challengesThe Lancet, 2003